Radiotherapy in stage I-III follicular non-Hodgkin lymphoma: Retrospective analysis of a series of 50 patients

Keyphrases

• Abdominopelvic 40%
• Ann Arbor 40%
• Clinical Staging 20%
• Complete Remission 80%
• Consecutive Patients 20%
• Event-free Survival 40%
• Extranodal Involvement 20%
• Extranodal Sites 20%
• Follicular Lymphoma 60%
• Follicular non-Hodgkin Lymphoma 100%
• Follow-up Interval 20%
• In(III) 20%
• In-field Recurrence 60%
• Involved Field Radiotherapy 20%
• Limited-stage 20%
• Lymphoma 40%
• Mantle Field 20%
• Median Overall Survival 20%
• Mini 20%
• Nodal Disease 20%
• Nodal Involvement 20%
• Nodal Regions 20%
• Overall Survival 40%
• Partial Remission 20%
• Radiation Dose 20%
• Radiation Field 20%
• Radiotherapy 100%
• Radiotherapy Alone 40%
• Radiotherapy Dose 20%
• Response Rate 20%
• Response-outcome 20%
• Retrospective Analysis 100%
• Tumor Bulk 20%
• Univariate Analysis 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Disease 40%
• Event Free Survival 40%
• Follicular Lymphoma 60%
• Neoplasm 20%
• Nonhodgkin Lymphoma 100%
• Overall Survival 60%
• Recurrent Disease 80%
• Remission 100%

Medicine and Dentistry

• Disease 25%
• Event Free Survival 25%
• Follicular Lymphoma 37%
• Involved-Field Radiotherapy 12%
• Neoplasm 12%
• Non-Hodgkin Lymphoma 100%
• Overall Survival 37%
• Radiation Therapy 100%
• Recurrent Disease 50%
• Univariate Analysis 12%